Aqueous Humor and Plasma Adiponectin Levels in Proliferative Diabetic Retinopathy Patients

REFERENCES

• Sheetz MJ, King GL. Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 2002;288:2579–2588.
   PubMed Web of Science ®Google Scholar
• Spranger J, Pfeiffer AF. New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes 2001;109 Suppl 2:S438–S450.
   PubMedGoogle Scholar
• Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature 2005;438:960–966.
   PubMed Web of Science ®Google Scholar
• Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84–89.
   PubMed Web of Science ®Google Scholar
• Díez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148:293–300.
   PubMed Web of Science ®Google Scholar
• Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med 2002;80:696–702.
   PubMed Web of Science ®Google Scholar
• Stefan N, Stumvoll M. Adiponectin – its role in metabolism and beyond. Horm Metab Res 2002;34:469–474.
   PubMed Web of Science ®Google Scholar
• Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005;48:1911–1918.
   PubMed Web of Science ®Google Scholar
• Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595–1599.
   PubMed Web of Science ®Google Scholar
• Hotta K, Funahashi T, Bodkin NL et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126–1133.
   PubMed Web of Science ®Google Scholar
• Higuchi A, Ohashi K, Kihara S, Walsh K, Ouchi N. Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-alpha expression. Circ Res 2009;104:1058–1065.
   PubMed Web of Science ®Google Scholar
• Bora PS, Kaliappan S, Lyzogubov VV et al. Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin. FEBS Lett 2007;581:1977–1982.
   PubMed Web of Science ®Google Scholar
• Yilmaz MI, Sonmez A, Acikel C et al. Adiponectin may play a part in the pathogenesis of diabetic retinopathy. Eur J Endocrinol 2004;151:135–140.
   Google Scholar
• Zietz B, Buechler C, Kobuch K, Neumeier M, Schölmerich J, Schäffler A. Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin gene mutations in Caucasian patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes 2008;116:532–536.
   PubMedGoogle Scholar
• Kato K, Osawa H, Ochi M et al. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Clin Endocrinol (Oxf) 2008;68:442–449.
   PubMedGoogle Scholar
• Chowdhury UR, Madden BJ, Charlesworth MC, Fautsch MP. Proteome analysis of human aqueous humor. Invest Ophthalmol Vis Sci 2010;51:4921–4931.
   PubMed Web of Science ®Google Scholar
• Sharma RK, Rogojina AT, Chalam KV. Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor. Mol Vis 2009;15:60–69.
   PubMed Web of Science ®Google Scholar
• Watkins PJ. Retinopathy. BMJ 2003;326:924–926.
   PubMed Web of Science ®Google Scholar
• Fautsch MP, Johnson DH. Characterization of myocilin-myocilin interactions. Invest Ophthalmol Vis Sci 2001;42:2324–2331.
   Google Scholar
• Fautsch MP, Vrabel AM, Peterson SL, Johnson DH. In vitro and in vivo characterization of disulfide bond use in myocilin complex formation. Mol Vis 2004;10:417–425.
   PubMedGoogle Scholar
• Yamauchi T, Kamon J, Ito Y et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423:762–769.
   PubMed Web of Science ®Google Scholar
• Ranscht B, Dours-Zimmermann MT. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron 1991;7:391–402.
   PubMed Web of Science ®Google Scholar
• Kos K, Harte AL, da Silva NF et al. Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab 2007;92:1129–1136.
   PubMed Web of Science ®Google Scholar
• Neumeier M, Weigert J, Buettner R et al. Detection of adiponectin in cerebrospinal fluid in humans. Am J Physiol Endocrinol Metab 2007;293:E965–E969.
   Web of Science ®Google Scholar
• Kusminski CM, McTernan PG, Schraw T et al. Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia 2007;50:634–642.
   Google Scholar
• El Sanharawi M, Kowalczuk L, Touchard E, Omri S, de Kozak Y, Behar-Cohen F. Protein delivery for retinal diseases: from basic considerations to clinical applications. Prog Retin Eye Res 2010;29:443–465.
   PubMed Web of Science ®Google Scholar
• Waki H, Yamauchi T, Kamon J et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003;278:40352–40363.
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998;47:1953–1959.
   PubMed Web of Science ®Google Scholar
• Cunha-Vaz J, Faria de Abreu JR, Campos AJ. Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol 1975;59:649–656.
   PubMed Web of Science ®Google Scholar
• Engler C, Krogsaa B, Lund-Andersen H. Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study. Graefes Arch Clin Exp Ophthalmol 1991;229:442–446.
   Google Scholar
• Vozarova de Courten B, Hanson RL, Funahashi T et al. Common Polymorphisms in the Adiponectin Gene ACDC Are Not Associated With Diabetes in Pima Indians. Diabetes 2005;54:284–289.
   Google Scholar
• Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26:439–451.
   PubMed Web of Science ®Google Scholar